Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sjogren Disease”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Early research (Phase 1)Looking for participantsNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Not applicableUnknownNCT02132585
What this trial is testing

Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction

Who this might be right for
Sjogren Syndrome
University of Roma La Sapienza 700
Not applicableStudy completedNCT07248306
What this trial is testing

Temporomandibular Joint Dysfunction in Sjögren's Syndrome

Who this might be right for
Sjogren Syndrome
Pamukkale University 27
Testing effectiveness (Phase 2)Ended earlyNCT02193490
What this trial is testing

DNase Treatment for Dry Eyes

Who this might be right for
Dry Eye
University of Illinois at Chicago 47
Large-scale testing (Phase 3)Active Not RecruitingNCT05350072
What this trial is testing

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Who this might be right for
Sjogren Syndrome
Novartis Pharmaceuticals 276
Not applicableStudy completedNCT01971957
What this trial is testing

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers

Who this might be right for
Sjogren-Larsson Syndrome (SLS)
University of Nebraska 20
Not applicableUnknownNCT03143413
What this trial is testing

Echo Systemic Sclerosis

Who this might be right for
Systemic SclerosisGougerot Sjogren SyndromeSicca-Asthenia-Polyalgia Syndrome
University Hospital, Clermont-Ferrand 100
Not applicableLooking for participantsNCT07249060
What this trial is testing

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Who this might be right for
Immune-Related Adverse EventsLupus Erythematosus, SystemicSjogren Syndrome+3 more
Hospital Universitario Araba 300
Testing effectiveness (Phase 2)Looking for participantsNCT06828042
What this trial is testing

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Sjogren Syndrome+3 more
Peking University Third Hospital 9
Large-scale testing (Phase 3)Study completedNCT02257957
What this trial is testing

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

Who this might be right for
Dry EyeSjogren Syndrome
Universidad Nacional de Colombia 30
Not applicableUnknownNCT03839069
What this trial is testing

Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis

Who this might be right for
Cicatrizing ConjunctivitisStevens-Johnson Syndrome Toxic Epidermal Necrolysis SpectrumSjogren Syndrome+3 more
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01647737
What this trial is testing

Green Tea Lozenges for the Management of Dry Mouth

Who this might be right for
XerostomiaSjogren SyndromeDry Mouth
Augusta University 60
Early research (Phase 1)WithdrawnNCT06411639
What this trial is testing

Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

Who this might be right for
Sjogren DiseaseSystemic Lupus Erythematosus
Novartis Pharmaceuticals
Not applicableStudy completedNCT03327870
What this trial is testing

Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population

Who this might be right for
Sjogren's SyndromeOral Health
National Institute of Dental and Craniofacial Research (NIDCR) 166
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Not applicableStudy completedNCT06398210
What this trial is testing

Investigation of the Effectiveness of Cognitive Exercise Therapy Approach in Patients With Primary Sjögren's Syndrome

Who this might be right for
Primer Sjogren's Syndrome
Kahramanmaras Sutcu Imam University 60
Early research (Phase 1)Looking for participantsNCT07041099
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Who this might be right for
SjögrenSjogren DiseaseSjogren's Syndrome
Cullinan Therapeutics Inc. 36
Not applicableStudy completedNCT07248436
What this trial is testing

"Validity and Reliability of Pelvic Floor Distress Inventory-20 in Primary Sjögren's Syndrome"

Who this might be right for
Sjogren Syndrome
Pamukkale University 10
Early research (Phase 1)Looking for participantsNCT03816345
What this trial is testing

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Who this might be right for
Autoimmune DiseaseCrohn DiseaseDermatomyositis+11 more
National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Load More Results